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Background
Neuropathic pain is a clinical manifestation characterized
by the presence of spontaneous pain, hyperalgesia and
allodynia. Several works have demonstrated that selective
NOS2 inhibitors might reverse the hypersensitivity to
pain induced by neuropathy [1,2]. Although these studies
suggest a potential role of NOS2 in the modulation of
neuropathic pain, the exact involvement of NOS2 in the
development of peripheral neuropathic pain remains
unclear. The aim of this study is to investigate the involve-
ment of nitric oxide synthesized by NOS2 in the develop-
ment and expression of neuropathic pain after total sciatic
nerve injury.
Materials and methods
Neuropathic pain induced by the chronic constriction of
the sciatic nerve (CCI) was performed in NOS2 knockout
(NOS2-KO) mice and their wild type (WT) littermates.
The development of mechanical and thermal allodynia,
and thermal hyperalgesia was evaluated by using the von
Frey filaments, cold plate and plantar tests, respectively.
Both, NOS2-KO and WT mice were tested in each para-
digm on days 1, 4, 7, 10, 14 and 21 after CCI induction.
We used sham-operated NOS2-KO and WT mice as con-
trols.
Results
Pre-surgical tactile and thermal withdrawal thresholds
were similar in both genotypes. In WT mice, the chronic
constriction of the sciatic nerve led to a neuropathic pain
syndrome characterized by a marked and long lasting
reduction of the paw withdrawal thresholds to mechani-
cal and thermal stimuli. In contrast, NOS2-KO mice failed
to display peripheral nerve injury-induced mechanical
and thermal allodynia as well as thermal hyperalgesia.
Indeed, significant differences were observed when com-
pared the paw withdrawal thresholds to mechanical and
thermal stimuli between the ipsilateral paws of both gen-
otypes (P < 0.001; Student's t-test). As expected, no signif-
icant changes in withdrawal thresholds to mechanical and
thermal stimuli were seen on the contralateral paw in
either WT or NOS2-KO operated mice, as well as on the
contralateral and ipsilateral paws of both WT and NOS2-
KO sham-operated mice. Although a significant decrease
of the thermal withdrawal latencies was observed in
NOS2-KO mice when compared the ipsilateral vs. contral-
ateral paw, from day 7 to 21 after CCI (P < 0.05; Student's
t-test).
Conclusion
These results indicate that nitric oxide synthesized by
NOS2 plays a critical role in the development and expres-
sion of peripheral neuropathic pain in mice.
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